Adverse event reporting

Adverse event reporting is the hospital disclosure system meant to bring threats to patient safety to regulators before their causes are settled. In the account of Somerset Medical Center, its central tension is plain: the rule required immediate reporting, while administrators chose to investigate internally first. The delay mattered not only as a regulatory failure but as a loss of time in a case where unexplained patient crises were still unfolding.

Definition and reporting threshold

New Jersey regulations required hospitals to report to the New Jersey Department of Health and Senior Services events occurring within a hospital that jeopardized patient health or safety. The report was to be immediate; the hospital did not have to know the cause before notifying the department. The rule thus treated uncertainty as no excuse for withholding notice: establishing what had happened could follow the report rather than precede it.

The book also gives a legal definition of an adverse event: an event resulting in death, loss of a body part, disability, or loss of bodily function lasting more than seven days or still present at discharge, where the harm could have been anticipated or prepared against but occurred because of an error or another system failure. This definition makes the reporting framework about consequential harm and preventability, not simply about whether anyone has already proved deliberate wrongdoing. A report can trigger scrutiny without itself settling cause or culpability.

The internal-investigation-first approach

At Somerset, administrators initially treated the unexplained incidents as matters for an internal inquiry. A July 10, 2003 email recorded that senior hospital officials had told a state representative they did not plan to report the incidents to the state health department or police until they had completed a thorough investigation. That sequence reversed the regulation’s logic: instead of notifying the department while the cause remained uncertain, the hospital made external reporting wait on its own attempt to resolve that uncertainty.

The distinction between investigative channels also mattered. New Jersey Poison Control Center director Dr. Steven Marcus warned that Somerset’s data were not ambiguous and feared that patients might continue to suffer while the administration delayed acknowledgment. Pharmacist Bruce Ruck repeatedly argued that the matter belonged to the police, while Marcus agreed. Police notification, however, did not replace the separate state reporting duty. The episode shows how a problem could be passed among institutional roles even as the obligation to report to the health department remained clear.

Somerset’s delay and escalating concern

Somerset had been conducting an internal investigation for five months when it approached the Somerset County Prosecutor’s Office about a sixth patient incident. The hospital described five earlier cases and the new one as unexplained incidents rather than declaring a homicide; five of the six patients had died. Its senior vice president summarized abnormal laboratory findings and life-threatening symptoms but would not say whether the cases were connected. Even after police became involved, investigators found that the internal inquiry had produced only four pieces of paper and no answers, and they lacked the medication records and interviews needed to build a case.

The reporting delay continued to trouble state officials. On September 26, a senior Department of Health staffer wrote that Somerset had reported a fourth incident that day even though it had occurred a month earlier, despite the hospital having been warned to report any additional patients. Department officials considered there might be enough reason to suspect foul play and sought permission to ask their legal office about referring the matter to the Attorney General’s office. Their concern was not simply that the incidents were difficult to explain; it was that the hospital knew of prior occurrences, had been told to report further ones, and still waited.

Safety procedures, disclosure, and accountability

The book distinguishes event reporting from measures intended to control access to drugs. At Saint Barnabas Medical Center, after unexplained insulin-related crises, the hospital introduced a stricter insulin sign-out procedure. Amy Loughren objected to signing an estimate of how much insulin remained in a vial, arguing that the quantity could not be accurately judged by sight. Her manager did not explain what had prompted the change. The new form was a control on medication handling, not a substitute for disclosing a patient-safety event to regulators; to Amy, its unexplained arrival signaled that something serious might have happened on her unit.

That information gap had consequences for trust and cooperation. As police interviews spread through the unit, nurses feared that suspicion might affect their jobs, and Amy—known as Charles Cullen’s friend and as someone who had resisted the insulin form—became afraid for herself. When a detective showed her Cullen’s Pyxis record from the night Reverend Florian Gall died, she could no longer dismiss the possibility that her friend had done something terrible. Her eventual help to investigators was difficult precisely because she was being asked to risk her job and deceive a friend while still uncertain whether the police were right.

Across these episodes, adverse event reporting functions as an early-warning obligation, not a verdict. Its purpose in the narrative is to expose the danger of making a hospital’s own investigation a precondition for outside notice: when reporting waits for certainty, evidence and accountability may arrive only after further harm and after the people best placed to act have lost time.